A revised draft proposal to create a process to expand the list of nutrients that require a warning under California's Proposition 65 "contains significant ambiguities" and should be dismissed, says the Council for Responsible Nutrition
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
The ups – and some downs – of the US FDA’s prescription, biosimilar, and generic user fees for FY 2026 are tabulated by the Pink Sheet.
In addition to impact from tariffs and executive suite changes, recent baggage for firms in the space include Perrigo divesting its branded Dermacosmetics business and Church & Dwight acquiring Touchland hand sanitizer brand.
Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.
